OBJECTIVES/HYPOTHESIS: To determine speech, eating, aesthetics, social disruption, and overall quality-of-life outcomes over a year period in patients who underwent transoral robotic surgery as part of carcinoma of unknown primary diagnosis and treatment. STUDY DESIGN: Observational prospective study. METHODS: Twenty-two patients who underwent transoral robotic surgery for the management of carcinoma of unknown primary were included. Patients prospectively completed the Head and Neck Cancer Inventory during a preoperative visit, and at 3-week, 3-month, 6-month, and 12-month postoperative visits. Patients' demographic, pathological, and follow-up information were also collected. RESULTS: The mean follow-up time was 19.8 months. There were overall declines in all quality of life scores during treatment period, which was followed by a continuous recovery. The scores immediately after transoral robotic surgery (3 weeks) were significantly higher than the scores after conclusion of adjuvant therapy (3 months) in multiple domains (P < .05) and the 6-month scores in speech (P = .02) and eating (P = .008) domains. All scores, except for eating (P = .01) returned to pretreatment levels at 1 year. Patients with detected primaries displayed similar quality-of-life scores compared to patients with occult primaries. Human papillomavirus status and type of adjuvant treatment had no significant impact on quality of life. CONCLUSIONS: Transoral robotic surgery is a promising, minimally invasive procedure for the surgical management of carcinoma of unknown primary. Patients maintain high functional and quality-of-life status at 1 year after surgery.
OBJECTIVES/HYPOTHESIS: To determine speech, eating, aesthetics, social disruption, and overall quality-of-life outcomes over a year period in patients who underwent transoral robotic surgery as part of carcinoma of unknown primary diagnosis and treatment. STUDY DESIGN: Observational prospective study. METHODS: Twenty-two patients who underwent transoral robotic surgery for the management of carcinoma of unknown primary were included. Patients prospectively completed the Head and Neck Cancer Inventory during a preoperative visit, and at 3-week, 3-month, 6-month, and 12-month postoperative visits. Patients' demographic, pathological, and follow-up information were also collected. RESULTS: The mean follow-up time was 19.8 months. There were overall declines in all quality of life scores during treatment period, which was followed by a continuous recovery. The scores immediately after transoral robotic surgery (3 weeks) were significantly higher than the scores after conclusion of adjuvant therapy (3 months) in multiple domains (P < .05) and the 6-month scores in speech (P = .02) and eating (P = .008) domains. All scores, except for eating (P = .01) returned to pretreatment levels at 1 year. Patients with detected primaries displayed similar quality-of-life scores compared to patients with occult primaries. Human papillomavirus status and type of adjuvant treatment had no significant impact on quality of life. CONCLUSIONS: Transoral robotic surgery is a promising, minimally invasive procedure for the surgical management of carcinoma of unknown primary. Patients maintain high functional and quality-of-life status at 1 year after surgery.
Authors: Agnes M Hurtuk; Anna Marcinow; Amit Agrawal; Matthew Old; Theodoros N Teknos; Enver Ozer Journal: Otolaryngol Head Neck Surg Date: 2011-08-31 Impact factor: 3.497
Authors: Catherine F Sinclair; Nancy L McColloch; William R Carroll; Eben L Rosenthal; Reneé A Desmond; J Scott Magnuson Journal: Arch Otolaryngol Head Neck Surg Date: 2011-11
Authors: Allen M Chen; Bao-Qing Li; D Gregory Farwell; Joseph Marsano; Srinivasan Vijayakumar; James A Purdy Journal: Int J Radiat Oncol Biol Phys Date: 2010-04-24 Impact factor: 7.038
Authors: Eric M Genden; Tamar Kotz; Charles C L Tong; Claris Smith; Andrew G Sikora; Marita S Teng; Stuart H Packer; William L Lawson; Johnny Kao Journal: Laryngoscope Date: 2011-08 Impact factor: 3.325
Authors: Peter C Levendag; David N Teguh; Peter Voet; Henri van der Est; Inge Noever; Wilhelmus J M de Kruijf; Inger-Karine Kolkman-Deurloo; Jean-Briac Prevost; Johan Poll; Paul I M Schmitz; Ben J Heijmen Journal: Radiother Oncol Date: 2007-08-21 Impact factor: 6.280
Authors: Marco Cianchetti; Anthony A Mancuso; Robert J Amdur; John W Werning; Jessica Kirwan; Christopher G Morris; William M Mendenhall Journal: Laryngoscope Date: 2009-12 Impact factor: 3.325
Authors: K Aro; L Bäck; V Loimu; K Saarilahti; S Rogers; H Sintonen; R Roine; Antti Mäkitie Journal: Eur Arch Otorhinolaryngol Date: 2015-07-28 Impact factor: 2.503
Authors: Satu Kainulainen; A M Koivusalo; R P Roine; T Wilkman; H Sintonen; J Törnwall; H Thorén; P Lassus Journal: Oral Maxillofac Surg Date: 2019-11-05